Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Advanced Parkinson DUODOPA-Treated Patients Observational Study Evaluating Long-Term Health Outcomes in Centers of Excellence (CADENCE)

NCT02485600 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02485600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02485600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Advanced Parkinson DUODOPA-Treated Patients Observational Study Evaluating Long-Term Health Outcomes in Centers of Excellence (CADENCE)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
October 19, 2015
Completion date
February 26, 2020
Enrollment
88 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease (pd)